OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) (Created Series Summary Page) |
Matthew Todd (talk | contribs) (Added project page for Series 4 MoA) |
||
| (11 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{OpenSourceMalaria}} | {{OpenSourceMalaria}} | ||
[[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] | A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | ||
[[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] | |||
[[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] | [[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] (being written up) | ||
[[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | |||
[[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] (final compounds being made) | |||
[[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines (TPs)''']] (currently active) | |||
[[OpenSourceMalaria:Triazolopyrazine_Series Mechanism of Action |'''Series 4: Mechanism of Action''']] (currently active) | |||
[[OpenSourceMalaria:Synthesis Branches |'''Synthetic Branches''']] | |||
[[OpenSourceMalaria:Obtaining Compounds for OSM |'''Obtaining Compounds for OSM''']] | |||
[[OpenSourceMalaria:Repurposing |'''Repurposing''']] | |||
[[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | [[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | ||
[[OpenSourceMalaria:Other Possible Series and Targets | '''Other Possible Series and Targets''']] | |||
[[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] | |||
Revision as of 05:03, 5 May 2016
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (being written up)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (final compounds being made)
Series 4: Triazolopyrazines (TPs) (currently active)
Series 4: Mechanism of Action (currently active)
